s-adenosylmethionine has been researched along with Heart Failure in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 8 (72.73) | 2.80 |
| Authors | Studies |
|---|---|
| Almanza-Aguilera, E; Alonso-Gómez, Á; Arós, F; Clish, CB; Corella, D; Dennis, C; Estruch, R; Fiol, M; Gómez-Gracia, E; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Lapetra, J; Li, J; Liang, L; Martínez-González, MÁ; Razquin, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wittenbecher, C | 1 |
| Aimo, A; Franco, AD; Morfino, P | 1 |
| Björk, S; Finckenberg, P; Kallijärvi, J; Kankainen, M; Kankuri, E; Lalowski, M; Leinonen, J; Mervaala, E; Purhonen, J; Soliymani, R; Tarkia, M | 1 |
| Hu, Z; Ni, Y; Shu, Q; Shui, B; Su, M; Zhang, Y; Zhao, H; Zhao, Q | 1 |
| Chen, WS; Cheng, ML; Liu, MH; Wang, CH | 1 |
| Caudal, A; Kolwicz, SC; McMillen, TS; Ritterhoff, J; Senn, T; Tian, R; Villet, O; Young, S | 1 |
| Bain, J; Felker, GM; Giamberardino, SN; Ilkayeva, O; Kraus, WE; McGarrah, RW; Newgard, CB; O'Connor, CM; Regan, JA; Shah, SH; Truby, LK | 1 |
| Kunii, H; Miyata, M; Nakazato, K; Owada, T; Saitoh, S; Sato, T; Sugimoto, K; Suzuki, H; Suzuki, S; Takeishi, Y; Yamaki, T; Yamauchi, H; Yoshihisa, A | 1 |
| Chandler, MP; Foster, AB; Fujioka, H; Hoit, BD; Hoppel, CL; McElfresh, TA; Minkler, PE; Okere, IC; Patel, HV; Patel, KK; Rennison, JH; Stoll, MS; Young, ME | 1 |
| Arenas, J; Börnstein, B; Campos, Y; de la Calzada, CS; Gómez, MA; Guillén, F; Martín, MA; Rubio, JC | 1 |
| Alhanti, B; Cheema, AK; Giczewska, A; Givertz, MM; Handy, DE; Joseph, J; Loscalzo, J; Mann, DL | 1 |
2 trial(s) available for s-adenosylmethionine and Heart Failure
| Article | Year |
|---|---|
Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Carnitine; Diabetes Mellitus, Type 2; Diet, Mediterranean; Heart Failure; Humans; Mediterranea; Nuts; Obesity; Olive Oil; Risk Factors | 2022 |
Associations of methyl donor and methylation inhibitor levels during anti-oxidant therapy in heart failure.
Topics: Aged; Allopurinol; Female; Free Radical Scavengers; Heart Failure; Humans; Hyperuricemia; Male; Methylation; Middle Aged; Oxidation-Reduction; Precision Medicine; S-Adenosylhomocysteine; S-Adenosylmethionine; Stroke Volume; Treatment Outcome; Uric Acid; Xanthine Oxidase | 2021 |
9 other study(ies) available for s-adenosylmethionine and Heart Failure
| Article | Year |
|---|---|
Plasma acylcarnitine, risk for heart failure or atrial fibrillation, and effects of the Mediterranean diet or obesity.
Topics: Atrial Fibrillation; Carnitine; Diet, Mediterranean; Heart Failure; Humans; Obesity | 2022 |
Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity.
Topics: Animals; Fatty Acids; Heart Failure; Mammals; Mice; Myocardial Infarction; Myocardium; Proteomics | 2023 |
Quantitative Metabolomics Reveals Heart Failure With Midrange Ejection Fraction as a Distinct Phenotype of Heart Failure.
Topics: Amino Acids; Analysis of Variance; Biomarkers; Carnitine; China; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Metabolome; Metabolomics; Middle Aged; Patient Acuity; Phenotype; Predictive Value of Tests; Prognosis; ROC Curve; Stroke Volume | 2021 |
Decreases in Circulating Concentrations of Short-Chain Acylcarnitines are Associated with Systolic Function Improvement After Decompensated Heart Failure.
Topics: Aged; Carnitine; Case-Control Studies; Esters; Fatty Acids; Female; Heart Failure; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Prognosis; Stroke Volume; Systole | 2020 |
Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
Topics: Acetyl-CoA Carboxylase; Animals; Carnitine; Disease Models, Animal; Energy Metabolism; Fatty Acids; Female; Gene Deletion; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Oxidation-Reduction; PPAR alpha; Sex Factors; Signal Transduction; Tamoxifen | 2021 |
Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.
Topics: Aged; Biomarkers; Carnitine; Clinical Trials as Topic; Diabetic Cardiomyopathies; Exercise Tolerance; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Metabolome; Metabolomics; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Tandem Mass Spectrometry; Time Factors | 2021 |
Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure.
Topics: Adult; Aged; Biomarkers; Carnitine; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Polysomnography; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Sleep Apnea Syndromes; Troponin T; Up-Regulation | 2015 |
Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure.
Topics: Acyl-CoA Dehydrogenase; Adiponectin; Animals; Blood Glucose; Carnitine; Dietary Fats; Disease Models, Animal; Electron Transport Chain Complex Proteins; Fatty Acids, Nonesterified; Heart Failure; Insulin; Leptin; Male; Mitochondria, Heart; Myocardial Contraction; Rats; Rats, Wistar; Triglycerides | 2008 |
Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure.
Topics: Biopsy; Carnitine; Carnitine O-Palmitoyltransferase; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardium; Stroke Volume | 2000 |